Press Releases

Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim

June 26, 2026 Read more

Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event

November 24, 2025 Read more

FIBRONEER™ global phase III trials

June 04, 2025 Read more

Boehringer Ingelheim unveiled a breathtaking installation of lungs at the Dubai Miracle Garden to raise awareness for ILD

February 25, 2025 Read more

Boehringer Ingelheim Launches Fast-acting Stroke Medication in the UAE

February 22, 2025 Read more

Boehringer’s nerandomilast meets primary endpoint in Phase III study

February 10, 2025 Read more

Saudi Health Council and Boehringer Ingelheim Join Forces to Strengthen Mental Health Policies

January 02, 2025 Read more

DHA and Boehringer Set Guinness World Records™ Title

November 19, 2024 Read more

Boehringer launches the Treatment for Three Interstitial Lung Diseases in Qatar

November 11, 2024 Read more

MEDEX and CRM summit discuss latest advances in CRM care

October 21, 2024 Read more

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

September 17, 2024 Read more